Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 110 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pancreatitis, Acute Clear all

Conditions: Post-ERCP Acute Pancreatitis
Interventions: Indomethacin, Lactated Ringer's Solution, Normal Saline, Placebo; Drug
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Acute Pancreatitis (AP), Gallstone Pancreatitis, Alcoholic Pancreatitis, Trauma Acute Pancreatitis, Hypertriglyceridemia Acute Pancreatitis, Idiopathic (Unknown) Acute Pancreatitis, Medication Induced Acute Pancreatitis, Cancer Acute Pancreatitis, Miscellaneous (i.e. Acute on Chronic Pancreatitis)
Interventions: Pentoxifylline, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 100 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute Pancreatitis (AP)
Interventions: Lactated Ringer's, Lactated Ringers Stroke Volume Based Dosing; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Los Angeles, California • Columbus, Ohio

Conditions: Chronic Pancreatitis, Chronic Pain, Acute Recurrent Pancreatitis
Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, Quantitative Sensory Test 3; Diagnostic Test
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 5 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Necrotizing Pancreatitis
Interventions: Using ABTHERA Advance without a Wittmann Patch; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 22 Years and older
Enrollment: 3 participants
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Acute Pancreatitis, Pancreatic Pseudocyst, Pancreatic Necrosis
Interventions: Endoscopic management of pancreatic fluid collections; Procedure
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Pancreatitis
Interventions: Fluid Management; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 0 Years to 18 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Cincinnati, Ohio • Norfolk, Virginia

Conditions: Pancreatic Cyst, Pancreatitis, Acute
Interventions: EUS-guided fine needle aspiration of pancreatic cysts; Procedure
Lead sponsor: Orlando Health, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Coronary Artery Disease, Congestive Heart Failure, Valvular Heart Disease, Atrial Fibrillation, Hypertension, Pyelonephritis, Acute Renal Failure, Renal Failure, Viral Hepatitis, Alcoholic Hepatitis, Steatohepatitis, Cirrhosis, Asthma, COPD, Bronchitis, Emphysema, Pneumonia, Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis, Diverticulitis, Peptic Ulcer Disease, Irritable Bowel Syndrome, Cholecystitis, Pancreatitis, Malabsorption Disorders, Celiac Sprue, Diabetes
Interventions: Not listed
Lead sponsor: Epic Research & Diagnostics, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 353 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pancreatitis, Diet, Food, and Nutrition, Diet, Pancreatic Disease, Enteral Nutrition
Interventions: Regular diet, Clear Liquid Diet; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pancreatitis
Interventions: Therapeutic Hypothermia; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Pancreatitis
Interventions: No intervention, this is an observational study; Diagnostic Test
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Baltimore, Maryland • Columbus, Ohio • Pittsburgh, Pennsylvania

Conditions: Pancreatitis, Chronic, Pancreatitis, Acute, Diabetes Mellitus
Interventions: Pioglitazone (PIO), Empagliflozin (EMPA); Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Rochester, Minnesota • Pittsburgh, Pennsylvania

Conditions: Necrotizing Pancreatitis
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Pancreatic Necrosis
Interventions: AXIOS™ stent, Double Pigtail Stents; Device
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Pancreatitis, Acute
Interventions: Pirfenidone Oral Tablet, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Rochester, Minnesota

Conditions: Acute Pancreatitis, Systemic Inflammatory Response Syndrome
Interventions: CM4620 Injectable Emulsion (Low Dose), CM4620 Injectable Emulsion (High Dose); Drug
Lead sponsor: CalciMedica, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 9
States / cities: Detroit, Michigan • Minneapolis, Minnesota • Saint Paul, Minnesota + 4 more

Conditions: Pancreatitis, Acute
Interventions: Fluid administration; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Pancreatitis, Acute Recurrent Pancreatitis
Interventions: Transabdominal ultrasound Shear wave elastography; Diagnostic Test
Lead sponsor: David Vitale MD; Other
Eligibility: 0 Years to 21 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Post-ERCP Acute Pancreatitis
Interventions: Tacrolimus capsule, Placebo, Rectal Indomethacin; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 4,874 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Pancreatitis
Interventions: Indomethacin, Placebo; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Acute Pancreatitis
Interventions: CyTOF Analysis; Diagnostic Test
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 5
States / cities: Los Angeles, California • Chicago, Illinois • Columbus, Ohio + 2 more

Conditions: Acute Pancreatitis
Interventions: Not listed
Lead sponsor: Enrique de-Madaria; Other
Eligibility: 18 Years to 79 Years
Enrollment: 525 participants
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Recurrent Acute Pancreatitis
Interventions: Pirfenidone, Placebo; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Birmingham, Alabama • Iowa City, Iowa • Rochester, Minnesota

Search by objective public record fields.

Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Pentoxifylline Treatment in Acute Pancreatitis (AP)

Stroke Volume-based Fluid Resuscitation in AP

Pancreatic Quantitative Sensory Testing (P-QST)

ABTHERA ADVANCE™ Use Without Wittman Patch

Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections

Comparing the Effects of Lactated Ringers and Normal Saline in Acute Pancreatitis

Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts

Prognostic Indicators as Provided by the EPIC ClearView

Regular vs. Clear Liquid Diet for Mild to Moderate Acute Pancreatitis

Therapeutic Hypothermia for Severe Acute Pancreatitis

Post Acute Pancreatitis Pancreatic Exocrine Insufficiency

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus

Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis

Study of a Lumen- Apposing, Covered, Self-Expanding Metal Stent (Axios™) Versus Multiple Double Pigtail Stents

Safety and Tolerability of Pirfenidone in Acute Pancreatitis

CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS

Lactated Ringer's Versus Normal Saline for Acute Pancreatitis

Incorporating Endoscopic Ultrasound and Elastography Towards Improving Outcomes of Pediatric Pancreatitis Management

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis

iMmune SignAtures and Clinical outComes in AP

Patient-reported Outcome Scale in Acute Pancreatitis

Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.